UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Pharmacokinetics/Genotype Associations for Major Cytochrome P450 Enzymes in Native and First- and Third-generation Japanese Populations: Comparison With Korean, Chinese, and Caucasian Populations

Clinical pharmacology and therapeutics, 2008-09, Vol.84 (3), p.347-361

2008

Volltextzugriff (PDF)

Biomarker analysis in a phase III study of pemetrexed–carboplatin versus etoposide–carboplatin in chemonaive patients with extensive-stage small-cell lung cancer

Annals of oncology, 2012-07, Vol.23 (7), p.1723-1729

2012

Volltextzugriff (PDF)

An association study of 43 SNPs in 16 candidate genes with atorvastatin response

The pharmacogenomics journal, 2005-01, Vol.5 (6), p.352-358

2005

Volltextzugriff (PDF)

High throughput genotyping for the detection of a single nucleotide polymorphism in NAD(P)H quinone oxidoreductase (DT diaphorase) using TaqMan probes

Molecular pathology, 1999-10, Vol.52 (5), p.295-299

1999

Volltextzugriff (PDF)

Distribution of mutations in the human xeroderma pigmentosum group A gene and their relationships to the functional regions of the DNA damage recognition protein

Human mutation, 1998, Vol.12 (2), p.103-113

1998

Volltextzugriff (PDF)

PD98059 Is an Equipotent Antagonist of the Aryl Hydrocarbon Receptor and Inhibitor of Mitogen-Activated Protein Kinase Kinase

Molecular pharmacology, 1998-03, Vol.53 (3), p.438-445

1998

Volltextzugriff (PDF)

Stable transformation of xeroderma pigmentosum group A cells with an XPA minigene restores normal DNA repair and mutagenesis of UV-treated plasmids

Carcinogenesis (New York), 1996-09, Vol.17 (9), p.1909-1917

1996

Volltextzugriff (PDF)

1887PDevelopment of a comprehensive next-generation targeted sequencing assay for detection of gene-fusions in solid tumors

Annals of oncology, 2019-10, Vol.30 (Supplement_5)

2019

Volltextzugriff (PDF)

Differential induction of Cyp1a1, Cyp1b1, Ahd4, and Nmo1 in murine skin tumors and adjacent normal epidermis by ligands of the Aryl hydrocarbon receptor

Molecular carcinogenesis, 1998-02, Vol.21 (2), p.135-146

1998

Volltextzugriff (PDF)

Pharmacogenomic analysis from a phase III study of pemetrexed plus carboplatin (PC) versus etoposide plus carboplatin (EC) in chemonaive patients (pts) with extensive-stage disease small cell lung cancer (ED-SCLC)

Journal of clinical oncology, 2009-05, Vol.27 (15_suppl), p.8030-8030

2009

Volltextzugriff (PDF)

Splice site mutations in a xeroderma pigmentosum group A patient with delayed onset of neurological disease

Mutation research, 1996-08, Vol.363 (3), p.171-177

1996

Volltextzugriff (PDF)

Characterization of the human XPA promoter

Gene, 1995-12, Vol.166 (2), p.341-342

1995

Volltextzugriff (PDF)

High-throughput genotyping method for glutathione S-transferase T1 and M1 gene deletions using TaqMan probes

Research communications in molecular pathology and pharmacology, 1999-01, Vol.103 (1), p.3

1999

Volltextzugriff (PDF)

A Novel Oncogenic RET Fusion Variant in NSCLC: RELCH-RET

Journal of thoracic oncology, 2021-10, Vol.16 (10), p.e95-e95

Myrand, Scott P.

2021

Volltextzugriff (PDF)

Technologies for measuring red blood cell deformability

Lab on a chip, 2022-03, Vol.22 (7), p.1254-1274

2022

Volltextzugriff (PDF)

Thymidylate Synthase Expression and Outcome of Patients Receiving Pemetrexed for Advanced Nonsquamous Non–Small-Cell Lung Cancer in a Prospective Blinded Assessment Phase II Clinical Trial

Journal of thoracic oncology, 2013-07, Vol.8 (7), p.930-939

2013

Volltextzugriff (PDF)

Association between gene expression profiles and clinical outcome of pemetrexed-based treatment in patients with advanced non-squamous non-small cell lung cancer: exploratory results from a phase II study

PloS one, 2014-09, Vol.9 (9), p.e107455

2014

Volltextzugriff (PDF)

Phase II evaluation of LY2603618, a first-generation CHK1 inhibitor, in combination with pemetrexed in patients with advanced or metastatic non-small cell lung cancer

Investigational new drugs, 2016-10, Vol.34 (5), p.625-635

2016

Volltextzugriff (PDF)

Randomized, Phase II, Placebo-Controlled, Double-Blind Study With and Without Enzastaurin in Combination With Paclitaxel and Carboplatin As First-Line Treatment Followed by Maintenance Treatment in Advanced Ovarian Cancer

Journal of clinical oncology, 2013-09, Vol.31 (25), p.3127-3132

2013

Volltextzugriff (PDF)

Microfluidic cell-phoresis enabling high-throughput analysis of red blood cell deformability and biophysical screening of antimalarial drugs

Lab on a chip, 2015-12, Vol.15 (23), p.4451-4460

2015

Volltextzugriff (PDF)

Reduced deformability of parasitized red blood cells as a biomarker for anti-malarial drug efficacy

Malaria journal, 2015-10, Vol.14 (421), p.428-428, Article 428

2015

Volltextzugriff (PDF)

Susceptibility of Cabbage Maggot Larvae (Diptera: Anthomyiidae) to Hypocreales Entomopathogenic Fungi

Journal of economic entomology, 2015-02, Vol.108 (1), p.34-44

2015

Volltextzugriff (PDF)

Microfluidic analysis of red blood cell deformability as a means to assess hemin-induced oxidative stress resulting from Plasmodium falciparum intraerythrocytic parasitism

Integrative biology (Cambridge), 2017-06, Vol.9 (6), p.519-528

2017

Volltextzugriff (PDF)

Open‐label, single‐arm, phase II study of enzastaurin in patients with follicular lymphoma

British journal of haematology, 2014-07, Vol.166 (1), p.91-97

2014

Volltextzugriff (PDF)

Abstract 3118: Next generation sequencing assay for detection of gene fusions and exon deletion events in tissue and liquid biopsy samples at very low frequency

Cancer research (Chicago, Ill.), 2020-08, Vol.80 (16_Supplement), p.3118-3118

2020

Volltextzugriff (PDF)

1 – 25 von 50

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(49)
Mit Volltextzugriff
(47)

Publikationsform

Artikel
(50)

Sprache

Englisch
(50)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(30)
Life Sciences & Biomedicine
(29)
Humans
(25)
Female
(13)
Aged
(12)
Middle Aged
(12)
Oncology
(12)
Male
(11)
Adult
(10)
Biological And Medical Sciences
(10)
Pharmacology & Pharmacy
(10)
Medical Sciences
(9)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(8)
Alleles
(5)
Antineoplastic Combined Chemotherapy Protocols - Adverse Effects
(5)
Biomarkers
(5)
Guanine - Analogs & Derivatives
(5)
Lung Neoplasms - Drug Therapy
(5)
Pemetrexed
(5)
Treatment Outcome
(5)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Pharmacokinetics/Genotype Associations for Major Cytochrome P450 Enzymes in Native and First- and Third-generation Japanese Populations: Comparison With Korean, Chinese, and Caucasian Populations

Biomarker analysis in a phase III study of pemetrexed–carboplatin versus etoposide–carboplatin in chemonaive patients with extensive-stage small-cell lung cancer

An association study of 43 SNPs in 16 candidate genes with atorvastatin response

High throughput genotyping for the detection of a single nucleotide polymorphism in NAD(P)H quinone oxidoreductase (DT diaphorase) using TaqMan probes

Distribution of mutations in the human xeroderma pigmentosum group A gene and their relationships to the functional regions of the DNA damage recognition protein

PD98059 Is an Equipotent Antagonist of the Aryl Hydrocarbon Receptor and Inhibitor of Mitogen-Activated Protein Kinase Kinase

Stable transformation of xeroderma pigmentosum group A cells with an XPA minigene restores normal DNA repair and mutagenesis of UV-treated plasmids

1887PDevelopment of a comprehensive next-generation targeted sequencing assay for detection of gene-fusions in solid tumors

Differential induction of Cyp1a1, Cyp1b1, Ahd4, and Nmo1 in murine skin tumors and adjacent normal epidermis by ligands of the Aryl hydrocarbon receptor

Pharmacogenomic analysis from a phase III study of pemetrexed plus carboplatin (PC) versus etoposide plus carboplatin (EC) in chemonaive patients (pts) with extensive-stage disease small cell lung cancer (ED-SCLC)

Splice site mutations in a xeroderma pigmentosum group A patient with delayed onset of neurological disease

Characterization of the human XPA promoter

High-throughput genotyping method for glutathione S-transferase T1 and M1 gene deletions using TaqMan probes

A Novel Oncogenic RET Fusion Variant in NSCLC: RELCH-RET

Technologies for measuring red blood cell deformability

Thymidylate Synthase Expression and Outcome of Patients Receiving Pemetrexed for Advanced Nonsquamous Non–Small-Cell Lung Cancer in a Prospective Blinded Assessment Phase II Clinical Trial

Association between gene expression profiles and clinical outcome of pemetrexed-based treatment in patients with advanced non-squamous non-small cell lung cancer: exploratory results from a phase II study

Phase II evaluation of LY2603618, a first-generation CHK1 inhibitor, in combination with pemetrexed in patients with advanced or metastatic non-small cell lung cancer

Randomized, Phase II, Placebo-Controlled, Double-Blind Study With and Without Enzastaurin in Combination With Paclitaxel and Carboplatin As First-Line Treatment Followed by Maintenance Treatment in Advanced Ovarian Cancer

Microfluidic cell-phoresis enabling high-throughput analysis of red blood cell deformability and biophysical screening of antimalarial drugs

Reduced deformability of parasitized red blood cells as a biomarker for anti-malarial drug efficacy

Susceptibility of Cabbage Maggot Larvae (Diptera: Anthomyiidae) to Hypocreales Entomopathogenic Fungi

Microfluidic analysis of red blood cell deformability as a means to assess hemin-induced oxidative stress resulting from Plasmodium falciparum intraerythrocytic parasitism

Open‐label, single‐arm, phase II study of enzastaurin in patients with follicular lymphoma

Abstract 3118: Next generation sequencing assay for detection of gene fusions and exon deletion events in tissue and liquid biopsy samples at very low frequency

Suchergebnisse filtern